UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044624
Receipt number R000050927
Scientific Title A comparison of the different electromyography-based neuromuscular monitor, the AF-201P and the TetraGraph, in rocuronium-induced neuromuscular block: A prospective comparative study
Date of disclosure of the study information 2021/06/22
Last modified on 2022/02/24 22:13:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A comparison of the different electromyography-based neuromuscular monitor, the AF-201P and the TetraGraph, in rocuronium-induced neuromuscular block: A prospective comparative study

Acronym

A comparison of AF201-P and TetraGraph

Scientific Title

A comparison of the different electromyography-based neuromuscular monitor, the AF-201P and the TetraGraph, in rocuronium-induced neuromuscular block: A prospective comparative study

Scientific Title:Acronym

A comparison of AF201-P and TetraGraph

Region

Japan


Condition

Condition

Patients undergoing general anesthesia

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of the study was to compare the responses obtained simultaneously from the new developed electromyography (EMG)-based neuromuscular monitor, the AF-201P and the TetraGraph, during rocuronium-induced neuromuscular block.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The time from administration of rocuronium to first appearance of PTC response

Key secondary outcomes

The supramaximal current, baseline compound action potential, time from administration of rocuronium to TOFC0 (onset time), time from administration of rocuronium to first reappearance of TOFC1 (time to TOFC1), time from administration of rocuronium to first reappearance of TOFC2 (time to TOFC2), and time from administration of sugammadex to TOF ratio 90% or higher


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

The AF-201P was placed on the right or left arm. TetraGraph was then placed on the contralateral arm.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with American Society of Anesthesiologists physical status classification 1-3.
After receiving written informed consent, patients aged twenty years old or more undergoing surgery with general anesthesia.

Key exclusion criteria

Patients with American Society of Anesthesiologists physical status classification 4 or more, patients with a history of allergic reaction to NMBAs, patients with hepatic disease, patients with neuromuscular disease, and patients who were receiving medication known to interfere with neuromuscular function.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hanae
Middle name
Last name Sato

Organization

Nihon University Itabashi Hospital

Division name

Department of Anesthesiology

Zip code

1738610

Address

30-1 Oyaguchi Kami-cho, Itabasi-Ku, Tokyo

TEL

0339728111

Email

nakamura.hanae@nihon-u.ac.jp


Public contact

Name of contact person

1st name Hanae
Middle name
Last name Sato

Organization

Nihon University Itabashi Hospital

Division name

Department of Anesthesiology

Zip code

1738610

Address

30-1 Oyaguchi Kami-cho, Itabasi-Ku, Tokyo

TEL

0339728111

Homepage URL


Email

nakamura.hanae@nihon-u.ac.jp


Sponsor or person

Institute

Nihon University Itabashi Hospital Department of Anesthesiology

Institute

Department

Personal name



Funding Source

Organization

Nihon University Itabashi Hospital Department of Anesthesiology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nihon University Itabashi Hospital, Clinical Research Judging Committee

Address

30-1 Oyaguchi Kami-cho, Itabasi-Ku, Tokyo

Tel

0339728111

Email

komoda.nozomi@nihon-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 06 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 06 Month 21 Day

Date of IRB

2021 Year 06 Month 11 Day

Anticipated trial start date

2021 Year 06 Month 22 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The aim of the study was to compare the responses obtained simultaneously from the new developed electromyography (EMG)-based neuromuscular monitor, the AF-201P and the TetraGraph, during rocuronium-induced neuromuscular block.


Management information

Registered date

2021 Year 06 Month 22 Day

Last modified on

2022 Year 02 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050927


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name